Alterations in endothelial activation biomarkers ICAM-1 and VCAM-1 following mitral regurgitation surgery

Saša Kostovski1, Jelena Milenkovic2, Boris Djindjic2

  • 1Clinic for Cardiosurgery, The Military Medical Academy, Belgrade, Serbia.

PubMed

Insights

Surgical correction of mitral regurgitation (MR) significantly reduces ICAM-1 levels, an inflammatory marker. This decline is linked to left ventricular (LV) size changes after surgery, indicating improved endothelial function.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Surgical Research

Background:

  • Degenerative mitral regurgitation (MR) causes hemodynamic changes and left ventricular (LV) remodeling.
  • Endothelial activation, marked by adhesion molecules like ICAM-1 and VCAM-1, plays a role in inflammation and LV dysfunction.

Purpose of the Study:

  • To evaluate endothelial activation during surgical correction of chronic MR.
  • To assess the association between adhesion molecules (ICAM-1, VCAM-1) and postsurgical LV dysfunction (LVD).

Main Methods:

  • Asymptomatic patients with severe degenerative MR (grade 3-4) were studied.
  • Transthoracic echocardiography and blood samples were collected pre- and post-surgery.
  • Circulating ICAM-1 and VCAM-1 levels were measured using ELISA.

Main Results:

  • Post-surgery, ejection fraction and LV dimensions decreased significantly.
  • ICAM-1 levels significantly declined (p=0.031), while VCAM-1 levels did not change.
  • Postoperative LVD occurred in 35.7% but wasn't correlated with adhesion molecules; however, ICAM-1 levels were associated with LV dilatation (EDD >5.6 cm).

Conclusions:

  • Serum ICAM-1 levels decrease after MR surgical correction, correlating with LV enlargement.
  • Endothelial activity dynamically changes post-surgery in MR patients.
  • Further research is needed to fully understand endothelial processes in MR.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
556
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
343
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
352
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
482
SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.3K
SN1 Reaction: Kinetics02:05

SN1 Reaction: Kinetics

In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.6K